CX NEWS
0.018-inch drug delivery platforms are as effective as 0.035-inch devices
Andrew Holden Interventionists can confidently use lower profile drug delivery platforms, based on data that shows 0.018-inch guidewire devices are non-inferior to 0.035-inch guidewires. In a Podium 1st presentation at Charing Cross [...]
Live case of challenging thoracic endovascular repair demonstrated using virtual reality at CX
Tilo Kölbel’s team, led on site in Hamburg, Germany, by Giuseppe Panuccio, successfully performed a thoracic endovascular aortic repair (TEVAR) on a 77-year old female patient with American Stroke Association (ASA) class III, and [...]
CX 2019: Highlights from the inaugural iWounds Workshop
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and [...]
Hear the latest thoughts on paclitaxel from global experts: their current practice and patient conversations
Following the latest information presented at the Charing Cross International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al, JAHA), hear from a multi-specialty panel of global experts who are discussing their [...]
Endoanchors add to therapy options for AAA
Frank Arko Using EndoAnchors to fix and seal endovascular aortic grafts is safe and effective for short-neck abdominal aortic aneurysm (AAA) patients, two-year data from the ANCHOR global registry have shown. Frank [...]
The impact of paclitaxel concerns on vascular access
As part of Wednesday’s CX Vascular Access Workshop in the Pillar Hall Learning Centre, there was a section of the programme on drug-coated balloon trial updates which ended with a panel discussion on whether [...]